摘要
血糖监测是糖尿病综合管理的重要组成部分，贯穿糖尿病治疗与疗效评估的全过程。自我血糖监测（SMBG）是血糖监测的基本形式，在不同的糖尿病阶段，因各自治疗措施和特点不同，需要相应的SMBG方案。糖化血红蛋白（Hb）A1c是反映长期血糖控制水平的金标准，但其检测方法需进行标准化。而动态血糖监测（CGM）可以提供连续、全面、可靠的全天血糖信息。糖化血清白蛋白（GA）反映短期内血糖变化比HbAlc敏感，是评价患者短期糖代谢控制情况的良好指标，二者有其自身的特点和优势，是上述监测方法的有效补充。
Blood glucose monitoring is an important component of the integrated management of diabetes ,which is performed throughout the entire process of the diabetes treatment and efficacy evaluation. Self-monitoring of blood glucose （SMBG） is the basic way of blood glucose monitoring, which varies due to different managements and stages of diabetes. Glyeosy[ated hemoglobin （Hh） Ale is the ＂ gold standard＂ of assessing glycemic control. Its measurement methods should be standardized. Continuous glucose monitoring （ CGM ） can provide consecutive, overall and reliable information of blood glucose throughout the day. Glycated albumin （GA） is more sensitive to short-term glyeemic changes than HbA1 c, so it is a good measurement of short-term glycemic control. Both CGM and GA each with its own characteristics and advantages are supplemental tools for the measurement methods above.
出处
《国际内分泌代谢杂志》
北大核心
2012年第1期1-4,共4页
International Journal of Endocrinology and Metabolism
基金
国家科技支撑计划（009BA180801）
关键词
血糖监测
指南
解读
Blood glucose monitoring
Guideline
Interpretation
